Family Medicine Initiative
APRIL 9, 2024
So, which patients should get them first? Patients ask me these questions fairly often, so I know it’s important for GPs to know the key facts. Yes, one year after stopping the medication, patients regain ½ – ⅔ of their previous weight loss: What are other clinical benefits? mg or placebo in 2019. semaglutide 2.4
Annals of Family Medicine
NOVEMBER 20, 2024
Health insurance instability may be particularly challenging for patients with diabetes who need regular chronic care management to reduce the risk of diabetes complications. 46,844 patients were diagnosed with diabetes during study period. Study Design: Retrospective observational cohort study.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Physician's Weekly
JUNE 23, 2025
Obesity drugs were not utilized often in young adults and adolescents despite high complication rates, prompting researchers to call for chronic, holistic care. Obesity in children and young adults is associated with the early development of several obesity-related complications,” wrote Theresa Hunter Gibble, PhD , and colleagues.
Common Sense Family Doctor
DECEMBER 14, 2024
Active surveillance is a management strategy that is intended to limit overtreatment of localized prostate cancer by monitoring patients with periodic PSA measurements and prostate biopsies to delay or avoid curative therapy (radical prostatectomy or radiation therapy) and its adverse effects. and 6.1%, respectively). in 2000 to 59.8%
PEMBlog
MARCH 4, 2025
Learning Objectives Describe the clinical presentation, epidemiology, and complications of Mycoplasma pneumoniae infections in pediatric patients, including its atypical manifestations. Clin Infect Dis 2019; 68:13. Now some patients can develop severe pulmonary complications, fortunately those are rare.
PEMBlog
SEPTEMBER 24, 2024
At that point, he was referred to pulmonology who started the patient on albuterol, manual chest physiotherapy, and a steroid inhaler with a plan for a fourth chest x-ray four weeks later. On arrival, the patient was febrile to 38.3C. Bronchopulmonary sequestration Our patient was diagnosed with bronchopulmonary sequestration (BPS).
FDA Law Blog
MAY 17, 2022
FDA approved FIRDAPSE in November 2018, with a period of orphan drug exclusivity, for the treatment of Lambert-Eaton Myasthenic Syndrome (“LEMS”) in adult patients. But in May 2019, FDA approved a second amifampridine drug product, Jacobus Pharmaceutical Company, Inc.’s and more likely 15-20.
Expert insights. Personalized for you.
130 
Let's personalize your content